My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 184

    1.

    Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice.

    Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabek L, Burge MJ, Masek MA, Shizuru JA.

    Diabetes. 2003 Jan;52(1):59-68.PMID: 12502494 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.

    Shizuru JA, Jerabek L, Edwards CT, Weissman IL.

    Biol Blood Marrow Transplant. 1996 Feb;2(1):3-14. Erratum in: Biol Blood Marrow Transplant 1997 Apr;3(1):50. PMID: 9078349 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.

    Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.

    Stem Cells. 2008 Feb;26(2):381-6. Epub 2007 Nov 1.PMID: 17975228 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection.

    Shizuru JA, Weissman IL, Kernoff R, Masek M, Scheffold YC.

    Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9555-60.PMID: 10920206 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.

    Li H, Kaufman CL, Ildstad ST.

    Surgery. 1995 Aug;118(2):192-7; discussion 197-8.PMID: 7638733 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.

    Beilhack GF, Landa RR, Masek MA, Shizuru JA.

    Diabetes. 2005 Jun;54(6):1770-9.PMID: 15919799 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.

    Chan WF, Razavy H, Luo B, Shapiro AM, Anderson CC.

    J Immunol. 2008 Apr 15;180(8):5177-86.PMID: 18390699 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.

    Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL.

    Blood. 2000 Mar 15;95(6):2175-82.PMID: 10706892 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

    Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M.

    Diabetes. 2004 Feb;53(2):376-83.PMID: 14747288 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential.

    Mueller YM, Cramer DE, Huang Y, Exner BG, Ildstad ST.

    Transplantation. 2002 Apr 27;73(8):1177-85.PMID: 11981407 [PubMed - indexed for MEDLINE]Related articles

    11.

    Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.

    Good RA.

    World J Surg. 2000 Jul;24(7):797-810. Review.PMID: 10833246 [PubMed - indexed for MEDLINE]Related articles

    12.

    MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

    Kupfer TM, Crawford ML, Pham K, Gill RG.

    J Immunol. 2005 Aug 15;175(4):2309-16.PMID: 16081800 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.

    Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L.

    Diabetes. 2001 Feb;50(2):270-6.PMID: 11272136 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice.

    Wang B, El-Badri NS, Cherry, Good RA.

    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14632-6.PMID: 9405664 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.

    Wu T, Levay-Young B, Heuss N, Sozen H, Kirchhof N, Sutherland DE, Hering B, Guo Z.

    Transplantation. 2002 Jul 15;74(1):22-7.PMID: 12134094 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells.

    Gandy KL, Weissman IL.

    Transplantation. 1998 Feb 15;65(3):295-304.PMID: 9484743 [PubMed - indexed for MEDLINE]Related articles

    17.

    The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.

    Makhlouf L, Kishimoto K, Smith RN, Abdi R, Koulmanda M, Winn HJ, Auchincloss H Jr, Sayegh MH.

    Diabetes. 2002 Nov;51(11):3202-10.PMID: 12401711 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.

    Uchida N, Tsukamoto A, He D, Friera AM, Scollay R, Weissman IL.

    J Clin Invest. 1998 Mar 1;101(5):961-6.PMID: 9486965 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.

    Guo Z, Wu T, Sozen H, Pan Y, Heuss N, Kalscheuer H, Sutherland DE, Blazar BR, Hering BJ.

    Transplantation. 2003 Apr 15;75(7):909-15.PMID: 12698073 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.

    Elkin G, Prigozhina TB, Slavin S.

    Exp Hematol. 2004 Jun;32(6):579-84.PMID: 15183899 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity